Patterns of Hepatitis B Virus Infection Serologic Markers among Blood Donors at a Tertiary Healthcare Facility in Central Nigeria

Main Article Content

Henry Chukwunonso Egbu
Haruna Isa Mohammed
Grace Rinmecit Pennap


Aims: This study was conducted to evaluate the patterns of hepatitis B virus infection serologic markers among blood donors at a tertiary healthcare Facility in Central Nigeria

Study Design: The study was a cross sectional study.

Place and Duration of Study: Keffi, Nasarawa State, between January and October, 2018.

Methodology: Blood sample (3 ml) was collected from each of the 400 consenting blood donors at Federal Medical Centre, Keffi, Nasarawa State and their socio-demographic information obtained using structured questionnaires. The sera were screened for HBV infection serologic markers (HBsAg, HBsAb, HBeAg, HBeAb and HBcAb) using HBV-5 rapid panel test kit (CTK Biotech. Inc. San Diego, USA). Data collected were analysed using Smith’s Statistical Package (version 2.8, California, USA) and P value of ≤ 0.05 was considered statistically significant.

Results: Majority of the 400 blood donors screened were males (391/400) and aged 25-34 years (203/400). Of these, 31(7.8%) were positive for HBsAg, 113(28.3%) for HBsAb, 11(2.8%) for HBeAg, 18(4.5%) for HBeAb and 78(19.5%) for HBcAb. Analysi;s of these sero-markers indicated that 1.5% of the donors had chronic infection with high viral replication, 1.2% had acute infection with high viral replication, 4.5% were carriers with low viral replication, 0.7% had occult infection, 0.5% were recently vaccinated, 15.5% were immuned due to successful vaccination, 12.8% were immuned as a result of natural previous exposure to the virus while 63.3% were not exposed to the virus. Age and gender were not associated with HBV infection in this study (P > 0.05). However there was statistically significant difference between age and gender with rate of HBcAb (P < 0.05).

Conclusion: We confirmed the presence occult HBV infection among prospective blood donors in the study area. Hence, HBV profiling for routine screening of blood donors should be made mandatory to avoid transfusion-associated hepatitis B virus infection.

Hepatitis B virus, infection, seromarkers, blood donors, Central Nigeria.

Article Details

How to Cite
Egbu, H. C., Mohammed, H. I., & Pennap, G. R. (2020). Patterns of Hepatitis B Virus Infection Serologic Markers among Blood Donors at a Tertiary Healthcare Facility in Central Nigeria. International Research Journal of Gastroenterology and Hepatology, 3(4), 28-36. Retrieved from
Original Research Article


World Health Organization. Hepatitis B; 2018. Accessed on 15 October, 2020 Available:

Oti BV, Pennap GR, Ngari HR. HBsAg and anti-HCV prevalence among pregnant women accessing antenatal care in a tertiary healthcare facility in Central Nigeria. Hepatology and Pancreatic Science. 2018;2-110–113.

Thio CL, Hawkins, CA. Hepatitis b virus and hepatitis delta virus, Mandell, Douglas and Bennett’s Principles and Practice of Infectious Diseases, 8th ed., Elsevier Inc, 2014;1815–1839.

World Health Organization. Hepatitis B fact sheet; 2015. Accessed on 10 October, 2020. Available:

Mbaawuaga EM, Iroegba CU, Ike AC. Hepatitis B virus serological patterns in Benue State, Nigeria. Open Journal of Medical Microbiology. 2014;4:1-10

Mohammed HI, Pennap GR, Oti VB, Adoga MP. Markers of hepatitis B virus infection in a subset of young people in Central Nigeria. Scientific Africa. 2019; 5:e00121.

Odimayo MS, Nwadioha SI, Ajayi AO. Hepatitis B serologic markers among individuals with hepatitis B surface antigen seropositivity in Makurdi, Nigeria. International Journal of Medicine and Medical Science. 2016;6(5):340-344.

Chen YS, Liang X, Hu JF. The serum markers of hepatitis B virus (HBV) infection and the natural history of chronic HBV infection. Zhongguo Yi Miao He Mian Yi. 2012;15(3):279-283.

Cento V, Van Hemert F, Neumann-Fraune M, Mirabelli C, Di Maio VC, Salpini R. et al. Anti-HBV treatment induces novel reverse transcriptase mutations with reflective effect on HBV S antigen. Journal of Infection. 2013;67:303–312.

Lok AS, McMahon BJ. Practice guidelines, Committee. American Association for the study of liver diseases, chronic Hepatitis B. Hepatology. 2011;34:1225-1241.

Centers for Disease Control and Prevention. Hepatitis B frequently asked questions for health professionals; 2017. Accessed on 3 October, 2020 Available:

Isa I, Aminu M, Abdullahi SA, Sani MA, Akafyi DE. Seroprevelence of hepatitis B virus in a tertiary institution in North Western Nigeria. African Journal of Microbiology Research. 2015;9(3):171- 179

Abah HO. Aminu M. Seroprevalence of hepatitis B virus serological markers among pregnant Nigerian women. Annals of African Medicine. 2016;15(1):20-27

Akwa VL. Binbol NL. Samaila KL. Marcus ND. Geographical perspective of Nasarawa State, Onaive Printing and Publishing Company Ltd, Keffi. 2007;503.

Naing L, Winn T. Rusli BN. Practical issues in calculating the sample size for prevalence studies. Archives of Orofacial Sciences. 2006;1:9-14.

Cheesbrough M. District laboratory practice in tropical countries. Low price edition. Cambridge University press, USA, 2010;297.

World Health Organization. Prevalence of hepatitis B virus infection in the World by Country; 2010. Accessed on 3 October, 2020 Available:

Okonkwo IO, Horsefall SJ, Okerentugba PO, Frank-Peterside N. HBV and HIV coinfections among intending blood donors in Portharcourt, Nigeria. Journal of Immunoassay and immunochemistry, 2015;36:359-367.

Alaku S, Mohammed HI. Pennap GR. Prevalence and determinants of hepatitis B virus infection among human immunodeficiency virus patients at a tertiary health care facility in Central Nigeria. World Journal of Advanced Research and Reviews. 2020;6(2):227-233.

Argaw B, Mihret A, Aseffa A, Tarekegne A, Hussen S, Wachamo D. et al. Sero-prevalence of hepatitis B virus markers and associated factors among children in Hawassa City, Southern Ethiopia. BMC Infectious Diseases. 2020;20:528-534.

Agbesor NI, Amala SE, Zaccheaus AJ. Hepatitis B virus profile among blood donors in the Federal Capital Territory Abuja, Nigeria. International journal of Science and Research. 2016;5(7):1668-1672.

Guimaraes LC, Brunini S, Guimaraes RA, Galdino H, Minamisava R, Da-Cunha VE. et al. Epidemiology of hepatitis B virus infection in people living in poverty in the Central-west region of Brazil. BMC Public Health. 2019;19-443-454.

Bello AC. Prevalence of hepatitis B virus markers in surgeons in Lagos, Nigeria. East African Medical Journal. 2010;77:283-285.

Goldsmith R, Zakaria S, Zakaria MS, Mabrouk MA, Hanafy AM, El-Kaliouby AH, El- Rifae M. Occupational exposure to hepatitis B virus in hospital personnel in Cairo, Egypt. Journal of Tropical Virology. 2013;46:283-290.

Mast EE, Weinbaum CM, Fiore AE. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. Morbidity and Mortality Weekly Report and Recommendation. 2006;55(16):1-33.

Egah DZ, Banwat EB, Audu ES, Iya D, Mandong BM, Anele AA, Gomwalk NE. Hepatitis surface antigen, hepatitis C and HIV antibodies in low risk blood donor group in Nigeria. Eastern Mediterranean Health Journal. 2015;13:1-6.

World Health Organization. Hepatitis B Fact Sheet No. 204; 2012. Accessed 20 February, 2019 Available:

Ogunfemi MK, Olawumi HO, Olokoba AB, Kagu MB, Biliaminu SA, Durowade KA. Prevalence of antibody to hepatitis B core antigen among hepatitis B surface antigen-negative blood donors in Ilorin, Nigeria: A cross-sectional study. Malawi Medical Journal. 2017;29(1):32-36.

Lavanya V, Viswanathan T, Arulsheeba S, Malarvizhi A, Moorthy K. Prevalence of HBV infection among blood donors with antibodies to HBV core antigen. International Journal of Medicine and Medical Sciences. 2012;4(6):128-137.

Said ZN, El-Sayed MH, Salama II, Aboel-Magd EK, Mahmoud MH, Setouhy ME. et al. Occult hepatitis B virus infection among Egyptian blood donors. World Journal of Hepatology. 2013;5(2):64-73.

Buseri F, Seiyaboh E, Jeremiah Z. Surveying infections among pregnant women in the Niger Delta, Nigeria. Journal of Global Infectious Disease. 2010;2:203-211.

Kuta FA, Adedeji AS, Damisa D. Prevalence of hepatitis B virus among prospective blood donors at University of Ilorin Teaching Hospital, Kwara State, Nigeria. Journal of Science and Multidisciplinary Research. 2014;2(2):38-41

Bagiyalakshim V, Gopal R, Elangovan RS. Prevalence of hepatitis B and C virus infection among voluntary blood donors at a tertiary care hospital blood bank-Tiruchirappali. International Journal of Scientific Study. 2017;4(10):105-108.

Pennap GR, Nwachukwu O, Ishaleku D, Ombugadu RJ. Hepatitis B virus carriage among students of a Nigerian Tertiary Institution. A cohort of eligible blood donors. Research Journal of Medical Sciences. 2011;5(2):90-93.

Mustapha SK, Jibrin YB, Musa AY. The prevalence of hepatitis B surface antigenemia in patients with human immunodeficiency virus infection in Gombe, Nigeria. Annal of African Medicine. 2014;4:10-1.

United Nations System in Nigeria. Nigerian Common Country Assessment. United Nations Systems in Nigeria, Geneva. 2001; 222.

Williams Z. Inducing tolerance to pregnancy. New England Journal of Medicine. 2012;367:1159-1161.